PMC:7347402 / 5724-6539
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 207 | 16-24 | Species | denotes | patients | Tax:9606 |
| 208 | 206-214 | Species | denotes | patients | Tax:9606 |
| 209 | 699-705 | Species | denotes | People | Tax:9606 |
| 210 | 355-361 | Chemical | denotes | oxygen | MESH:D010100 |
| 211 | 74-78 | Disease | denotes | died | MESH:D003643 |
| 212 | 551-571 | Disease | denotes | secondary infections | MESH:D060085 |
| 213 | 606-614 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T62 | 561-571 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T63 | 606-614 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T42 | 52-53 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T16 | 254-263 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T17 | 355-361 | Chemical | denotes | oxygen | http://purl.obolibrary.org/obo/CHEBI_25805 |
| T18 | 492-505 | Chemical | denotes | antimicrobial | http://purl.obolibrary.org/obo/CHEBI_33281 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T41 | 0-201 | Sentence | denotes | All consecutive patients included in this study had a definitive outcome (died, discharged or still hospitalised) within 28 days, with the time period spanning from 24 January 2020 to 10 February 2020. |
| T42 | 202-731 | Sentence | denotes | All patients received standard treatment, including antiviral therapy, respiratory support (nasal cannulation, mask oxygenation, high-flow nasal cannula oxygen therapy, non-invasive positive pressure ventilation or invasive mechanical ventilation), symptomatic and supportive treatment and antimicrobial therapy, as appropriate, to prevent or treat secondary infections, which was in accordance with the COVID-19 diagnosis and treatment protocols released by the National Health Commission of the People’s Republic of China [16]. |
| T43 | 732-815 | Sentence | denotes | This retrospective project did not interfere with the course of medical management. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T63 | 74-78 | GO:0016265 | denotes | died |
| T64 | 273-284 | UBERON:0001004 | denotes | respiratory |
| T65 | 294-299 | UBERON:0000004 | denotes | nasal |
| T66 | 341-346 | UBERON:0000004 | denotes | nasal |
| T67 | 492-505 | CHEBI:35718;CHEBI:35718 | denotes | antimicrobial |
| T68 | 606-614 | SP_7 | denotes | COVID-19 |
| T79135 | 74-78 | GO:0016265 | denotes | died |
| T45191 | 273-284 | UBERON:0001004 | denotes | respiratory |
| T49513 | 294-299 | UBERON:0000004 | denotes | nasal |
| T7907 | 341-346 | UBERON:0000004 | denotes | nasal |
| T12691 | 492-505 | CHEBI:35718;CHEBI:35718 | denotes | antimicrobial |
| T32460 | 606-614 | SP_7 | denotes | COVID-19 |